News

iVeena Announces IND Submission to the U.S. FDA for a Phase 2 Clinical Trial for Pediatric Myopia
SALT LAKE CITY, May 29, 2025--iVeena Delivery Systems Inc. ("iVeena"), a biopharmaceutical company advancing IVMED-85 for the treatment of pediatric myopia, today announced the submission of an ...